DeannaLee M Beauvais Selected Research

Syndecan-4

6/2003

Syndecan-1-mediated cell spreading requires signaling by alphavbeta3 integrins in human breast carcinoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

DeannaLee M Beauvais Research Topics

Disease

6	Neoplasms (Cancer) 01/2023 - 01/2004
5	Carcinoma (Carcinomatosis) 01/2023 - 06/2003
4	Breast Neoplasms (Breast Cancer) 01/2022 - 06/2003
3	Carcinogenesis 01/2022 - 03/2009
2	Squamous Cell Carcinoma of Head and Neck 01/2023 - 01/2022
2	Neoplasm Metastasis (Metastasis) 10/2019 - 11/2010
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2023
1	Leukemia 01/2022
1	Multiple Myeloma 01/2016

Drug/Important Bio-Agent (IBA)

5	SyndecansIBA 01/2022 - 06/2003
5	Syndecan-1 (Syndecan 1)IBA 10/2019 - 06/2003
5	IntegrinsIBA 10/2014 - 06/2003
4	Peptides (Polypeptides)IBA 01/2023 - 03/2009
3	Phosphotransferases (Kinase)IBA 01/2022 - 10/2014
2	tyrosine receptor (receptor, tyrosine)IBA 01/2022 - 10/2014
1	adhesion receptorIBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	PeptidomimeticsIBA 01/2023
1	ErbB Receptors (EGF Receptor)IBA 01/2022
1	RON proteinIBA 01/2022
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2022
1	Syndecan-2IBA 01/2022
1	EnzymesIBA 10/2019
1	heparanaseIBA 10/2019
1	Integrin alpha4beta1 (VLA-4)IBA 10/2019
1	Cell-Penetrating PeptidesIBA 10/2014
1	Proteins (Proteins, Gene)FDA Link 03/2009
1	VitronectinIBA 10/2004
1	Integrin alphaVbeta3IBA 10/2004
1	AntibodiesIBA 06/2003
1	Syndecan-4IBA 06/2003

Therapy/Procedure

2	Therapeutics 01/2023 - 01/2022
1	Ligation 01/2023